View of CLINICAL SIGNIFICANCE OF MYOFASCIAL TRIGGER POINTS IN CERVICOGENIC HEADACHE: FROM PHENOTYPING TO TARGETED BOTULINUM TOXIN TYPE A THERAPY

Return to Article Details CLINICAL SIGNIFICANCE OF MYOFASCIAL TRIGGER POINTS IN CERVICOGENIC HEADACHE: FROM PHENOTYPING TO TARGETED BOTULINUM TOXIN TYPE A THERAPY Download Download PDF